array:25 [
  "pii" => "S0211699515001563"
  "issn" => "02116995"
  "doi" => "10.1016/j.nefro.2015.07.008"
  "estado" => "S300"
  "fechaPublicacion" => "2016-01-01"
  "aid" => "104"
  "copyright" => "Sociedad Española de Nefrología"
  "copyrightAnyo" => "2015"
  "documento" => "simple-article"
  "crossmark" => 0
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "cor"
  "cita" => "Nefrologia. 2016;36:82-5"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 5702
    "formatos" => array:3 [
      "EPUB" => 293
      "HTML" => 4655
      "PDF" => 754
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:20 [
      "pii" => "S2013251416000092"
      "issn" => "20132514"
      "doi" => "10.1016/j.nefroe.2016.01.008"
      "estado" => "S300"
      "fechaPublicacion" => "2016-01-01"
      "aid" => "104"
      "copyright" => "Sociedad Española de Nefrología"
      "documento" => "simple-article"
      "crossmark" => 0
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "cor"
      "cita" => "Nefrologia (English Version). 2016;36:82-5"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 4074
        "formatos" => array:3 [
          "EPUB" => 290
          "HTML" => 3156
          "PDF" => 628
        ]
      ]
      "en" => array:11 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>"
        "titulo" => "Atypical haemolytic-uraemic syndrome in a young patient with renal&#44; neurological&#44; ocular and cardiovascular involvement"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "82"
            "paginaFinal" => "85"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "S&#237;ndrome hemol&#237;tico ur&#233;mico at&#237;pico en un paciente joven con compromiso renal&#44; neurol&#243;gico&#44; ocular y cardiovascular"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0005"
            "etiqueta" => "Fig&#46; 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 1906
                "Ancho" => 2492
                "Tamanyo" => 304841
              ]
            ]
            "descripcion" => array:1 [
              "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Results of laboratory investigations during treatment&#46;</p> <p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Laboratory parameters during treatment&#58; 13 sessions of plasma exchange &#40;blue arrows&#41;&#59; total 4 red cell transfusions &#40;red arrow&#41;&#59; eculizumab&#44; started on 29 September 2014 &#40;green arrow&#41;&#46; The LDH values are at a scale of 1<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleSup">2</span> and the platelet values are at a scale of 1<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>10<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">4</span></a>&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "John Fredy Nieto-R&#237;os, Lina Mar&#237;a Serna-Higuita, Estefan&#237;a Calle-Botero, Catalina Ocampo-Kohn, Arbey Aristizabal-Alzate, M&#243;nica Zuluaga-Quintero, Gustavo Zuluaga-Valencia"
            "autores" => array:7 [
              0 => array:2 [
                "nombre" => "John Fredy"
                "apellidos" => "Nieto-R&#237;os"
              ]
              1 => array:2 [
                "nombre" => "Lina Mar&#237;a"
                "apellidos" => "Serna-Higuita"
              ]
              2 => array:2 [
                "nombre" => "Estefan&#237;a"
                "apellidos" => "Calle-Botero"
              ]
              3 => array:2 [
                "nombre" => "Catalina"
                "apellidos" => "Ocampo-Kohn"
              ]
              4 => array:2 [
                "nombre" => "Arbey"
                "apellidos" => "Aristizabal-Alzate"
              ]
              5 => array:2 [
                "nombre" => "M&#243;nica"
                "apellidos" => "Zuluaga-Quintero"
              ]
              6 => array:2 [
                "nombre" => "Gustavo"
                "apellidos" => "Zuluaga-Valencia"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "es" => array:9 [
          "pii" => "S0211699515001563"
          "doi" => "10.1016/j.nefro.2015.07.008"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "es"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699515001563?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251416000092?idApp=UINPBA000064"
      "url" => "/20132514/0000003600000001/v2_201703300133/S2013251416000092/v2_201703300133/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S021169951500154X"
    "issn" => "02116995"
    "doi" => "10.1016/j.nefro.2015.08.006"
    "estado" => "S300"
    "fechaPublicacion" => "2016-01-01"
    "aid" => "102"
    "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "cor"
    "cita" => "Nefrologia. 2016;36:85-6"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 4731
      "formatos" => array:3 [
        "EPUB" => 366
        "HTML" => 3629
        "PDF" => 736
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>"
      "titulo" => "An unusual case of peritonitis after vaginal leak in a patient on peritoneal dialysis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "85"
          "paginaFinal" => "86"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Un caso infrecuente de peritonitis tras fuga vaginal en un paciente en di&#225;lisis peritoneal"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1606
              "Ancho" => 900
              "Tamanyo" => 146504
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Arrows shows vaginal leak&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Ali Bakan, Alihan Oral, Osman Kostek, Sabahat Al&#305;&#351;&#305;r Ecder, Ali R&#305;za Odaba&#351;"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "Ali"
              "apellidos" => "Bakan"
            ]
            1 => array:2 [
              "nombre" => "Alihan"
              "apellidos" => "Oral"
            ]
            2 => array:2 [
              "nombre" => "Osman"
              "apellidos" => "Kostek"
            ]
            3 => array:2 [
              "nombre" => "Sabahat Al&#305;&#351;&#305;r"
              "apellidos" => "Ecder"
            ]
            4 => array:2 [
              "nombre" => "Ali R&#305;za"
              "apellidos" => "Odaba&#351;"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S021169951500154X?idApp=UINPBA000064"
    "url" => "/02116995/0000003600000001/v1_201602110042/S021169951500154X/v1_201602110042/en/main.assets"
  ]
  "itemAnterior" => array:20 [
    "pii" => "S0211699515001666"
    "issn" => "02116995"
    "doi" => "10.1016/j.nefro.2015.08.010"
    "estado" => "S300"
    "fechaPublicacion" => "2016-01-01"
    "aid" => "114"
    "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "cor"
    "cita" => "Nefrologia. 2016;36:80-1"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 10311
      "formatos" => array:3 [
        "EPUB" => 330
        "HTML" => 9207
        "PDF" => 774
      ]
    ]
    "es" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>"
      "titulo" => "Una causa infrecuente de hemoperitoneo espont&#225;neo en un paciente en di&#225;lisis peritoneal"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "80"
          "paginaFinal" => "81"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "An uncommon cause of spontaneous hemoperitoneum in a peritoneal dialysis patient"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 976
              "Ancho" => 897
              "Tamanyo" => 174069
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Imagen en TAC de un n&#243;dulo hiperdenso en la regi&#243;n posterior del fundus g&#225;strico&#44; compatible con seudoaneurisma de la arteria g&#225;strica izquierda&#44; con un hematoma subyacente&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Carlos Hidalgo-Ordo&#241;ez, J&#46; Emilio S&#225;nchez-Alvarez, Carmen Rodr&#237;guez-Su&#225;rez"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Carlos"
              "apellidos" => "Hidalgo-Ordo&#241;ez"
            ]
            1 => array:2 [
              "nombre" => "J&#46; Emilio"
              "apellidos" => "S&#225;nchez-Alvarez"
            ]
            2 => array:2 [
              "nombre" => "Carmen"
              "apellidos" => "Rodr&#237;guez-Su&#225;rez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S2013251416000316"
        "doi" => "10.1016/j.nefroe.2016.03.001"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251416000316?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699515001666?idApp=UINPBA000064"
    "url" => "/02116995/0000003600000001/v1_201602110042/S0211699515001666/v1_201602110042/es/main.assets"
  ]
  "es" => array:15 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>"
    "titulo" => "S&#237;ndrome hemol&#237;tico ur&#233;mico at&#237;pico en un paciente joven con compromiso renal&#44; neurol&#243;gico&#44; ocular y cardiovascular"
    "tieneTextoCompleto" => true
    "saludo" => "<span class="elsevierStyleItalic">Sr&#46; Director&#58;</span>"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "82"
        "paginaFinal" => "85"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "John Fredy Nieto-R&#237;os, Lina Mar&#237;a Serna-Higuita, Estefan&#237;a Calle-Botero, Catalina Ocampo-Kohn, Arbey Aristizabal-Alzate, M&#243;nica Zuluaga-Quintero, Gustavo Zuluaga-Valencia"
        "autores" => array:7 [
          0 => array:3 [
            "nombre" => "John Fredy"
            "apellidos" => "Nieto-R&#237;os"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          1 => array:4 [
            "nombre" => "Lina Mar&#237;a"
            "apellidos" => "Serna-Higuita"
            "email" => array:2 [
              0 => "lm&#46;serna&#64;hotmail&#46;com"
              1 => "johnfredynieto&#64;gmail&#46;com"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Estefan&#237;a"
            "apellidos" => "Calle-Botero"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Catalina"
            "apellidos" => "Ocampo-Kohn"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "Arbey"
            "apellidos" => "Aristizabal-Alzate"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "M&#243;nica"
            "apellidos" => "Zuluaga-Quintero"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          6 => array:3 [
            "nombre" => "Gustavo"
            "apellidos" => "Zuluaga-Valencia"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:3 [
            "entidad" => "Nefr&#243;logo Hospital Pablo Tob&#243;n Uribe&#8211;Universidad de Antioquia&#44; Medell&#237;n&#44; Colombia"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Residente de Medicina Interna Universidad Pontificia Bolivariana&#44; Medell&#237;n&#44; Colombia"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "<span class="elsevierStyleItalic">Autor para correspondencia</span>&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Atypical haemolytic-uraemic syndrome in a young patient with renal&#44; neurological&#44; ocular and cardiovascular involvement"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1906
            "Ancho" => 2492
            "Tamanyo" => 284593
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Evoluci&#243;n de los ex&#225;menes de laboratorio durante el tratamiento&#46;</p> <p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Evoluci&#243;n de los par&#225;metros de laboratorio durante el tratamiento recibido&#58; recambios plasm&#225;ticos 13 sesiones &#40;flecha azules&#41;&#44; transfusiones total 4 &#40;flecha roja&#41;&#59; adem&#225;s&#44; se inici&#243; eculizumab el 29 de septiembre de 2014 &#40;flecha verde&#41;&#46; Los valores de LDH se encuentran en escala de 1<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleSup">2</span> y los valores de plaquetas se encuentran en escala de 1<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleSup">4</span>&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Presentamos el caso de un paciente de 23 a&#241;os&#44; con 3 meses de evoluci&#243;n de cefalea&#44; p&#233;rdida de la visi&#243;n&#44; hiporexia y orina espumosa&#46; En la &#250;ltima semana&#58; postraci&#243;n en cama&#44; alteraci&#243;n del sensorio&#44; oliguria y disnea&#46; En la evaluaci&#243;n inicial se encontr&#243; en malas condiciones generales&#44; somnoliento&#44; desorientado&#44; taquic&#225;rdico&#44; hipertenso&#44; taquipneico&#44; con asterixis&#59; aliento ur&#233;mico e ingurgitaci&#243;n yugular&#59; ruidos respiratorios con cr&#233;pitos bibasales y edema de miembros inferiores&#46; Pruebas de laboratorio al ingreso&#58; azoados elevados&#44; acidosis metab&#243;lica con ani&#243;n GAP alto&#44; anemia hemol&#237;tica microangiop&#225;tica no inmune y trombocitopenia &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41;&#46; Se solicitaron estudios complementarios&#44; incluida actividad de ADAMTS13&#44; y perfil inmunol&#243;gico e infeccioso&#44; que fueron negativos &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41;&#46; Se inici&#243; tratamiento con hemodi&#225;lisis&#44; labetalol parenteral&#44; transfusi&#243;n de gl&#243;bulos rojos y recambios plasm&#225;ticos&#46; Una vez controlada la uremia y la crisis hipertensiva se realiz&#243; una evaluaci&#243;n oftalmol&#243;gica que report&#243; p&#233;rdida marcada de la agudeza visual &#40;OD&#58; 20&#47;400<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>1&#59; OI&#58; 20&#47;150<span class="elsevierStyleHsp" style=""></span>&#8722;<span class="elsevierStyleHsp" style=""></span>1&#41; y retinopat&#237;a hipertensiva&#46; Al s&#233;ptimo d&#237;a se control&#243; la actividad hemol&#237;tica&#44; lo que permiti&#243; suspender los recambios plasm&#225;ticos&#59; sin embargo&#44; present&#243; reca&#237;da 48<span class="elsevierStyleHsp" style=""></span>h despu&#233;s&#44; raz&#243;n por la cual se reiniciaron nuevamente y se obtuvo el diagn&#243;stico definitivo de SHUa &#40;<a class="elsevierStyleCrossRef" href="#fig0005">fig&#46; 1</a>&#41;&#46; Se inici&#243; tratamiento con eculizumab y se suspendieron los recambios plasm&#225;ticos&#44; con adecuada evoluci&#243;n posterior&#44; con recuperaci&#243;n de su visi&#243;n &#40;20&#47;30 en ambos ojos&#41;&#44; aunque continu&#243; con requerimiento de di&#225;lisis&#46; Se realiz&#243; estudio gen&#233;tico para detectar mutaciones del complemento asociadas con SHUa&#44; el cual fue negativo para las mutaciones conocidas &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41;&#46; En el seguimiento a 9 meses el paciente continuaba dependiente de di&#225;lisis&#44; por lo cual se diagnostic&#243; enfermedad renal cr&#243;nica terminal &#40;ERCT&#41; secundaria a SHUa y se activ&#243; para trasplante renal&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0010" class="elsevierStylePara elsevierViewall">El SHUa es una enfermedad gen&#233;tica cr&#243;nica ultra-rara&#44; ocasionada por una alteraci&#243;n en la regulaci&#243;n del complemento y que puede producir secuelas graves en m&#250;ltiples &#243;rganos e incluso la muerte<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#8211;4</span></a>&#46; Se caracteriza por la tr&#237;ada de anemia hemol&#237;tica microangiop&#225;tica&#44; trombocitopenia e insuficiencia renal&#44; pero puede producir alteraci&#243;n en cualquier &#243;rgano<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;2</span></a>&#46; Nuestro paciente present&#243; compromiso renal&#44; hematol&#243;gico&#44; neurol&#243;gico&#44; cardiovascular y ocular&#44; este &#250;ltimo hallazgo&#44; poco reportado en la literatura<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;2</span></a>&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">En m&#225;s de la mitad de los pacientes con SHUa se puede identificar la mutaci&#243;n del complemento o de otras mol&#233;culas que ocasiona la alteraci&#243;n en su regulaci&#243;n&#59; sin embargo&#44; no se requiere el estudio gen&#233;tico para confirmar el diagn&#243;stico e iniciar el tratamiento&#44; pero s&#237; es ideal realizarlo para establecer el pron&#243;stico&#44; ya que hay algunas mutaciones m&#225;s agresivas que otras&#59; adem&#225;s&#44; el estudio gen&#233;tico permite planear de una forma m&#225;s adecuada el trasplante renal en los pacientes que lo requieren<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;2&#44;5</span></a>&#46; Hasta en el 30&#37; de los enfermos no se documenta mutaci&#243;n<a class="elsevierStyleCrossRefs" href="#bib0070"><span class="elsevierStyleSup">4&#44;6</span></a>&#44; como fue el caso de nuestro paciente&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">El tratamiento de elecci&#243;n del SHUa es eculizumab&#44; anticuerpo monoclonal humanizado que bloquea la escisi&#243;n de la fracci&#243;n C5 del complemento y&#44; por lo tanto&#44; evita la liberaci&#243;n de la anafilotoxina C5a y la formaci&#243;n del complejo de ataque de membrana C5b-9&#44; evitando as&#237; el da&#241;o endotelial y la generaci&#243;n de microangiopat&#237;a tromb&#243;tica<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;7&#44;8</span></a>&#46; Como prerrequisito para el inicio de eculizumab se debe aplicar la vacuna contra el meningococo e iniciar profilaxis antibi&#243;tica dirigida al meningococo&#44; mientras la vacuna surte efecto&#46; Cuanto m&#225;s r&#225;pido se inicie eculizumab en los pacientes con SHUa&#44; mayor ser&#225; la posibilidad de recuperaci&#243;n y menores ser&#225;n las secuelas<a class="elsevierStyleCrossRefs" href="#bib0075"><span class="elsevierStyleSup">5&#44;9</span></a>&#46; Sin embargo&#44; mientras se realiza el diagn&#243;stico de este s&#237;ndrome&#44; los recambios plasm&#225;ticos pueden estabilizar la actividad hemol&#237;tica del paciente y&#44; por lo tanto&#44; se deben iniciar precozmente ante el cuadro cl&#237;nico de una microangiopat&#237;a tromb&#243;tica&#44; teniendo en cuenta que se debe tomar previamente la actividad de la ADAMTS13 y el perfil de autoanticuerpos para no enmascarar otros diagn&#243;sticos<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;5&#44;7</span></a>&#46; Si al final el diagn&#243;stico es un SHUa&#44; el tratamiento debe ser cambiado a eculizumab&#44; ya que la terapia plasm&#225;tica a largo plazo no ha mostrado cambiar el curso devastador del SHUa<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;5&#44;9&#44;10</span></a>&#46; En el caso de nuestro paciente&#44; inicialmente se realizaron recambios plasm&#225;ticos&#44; logr&#225;ndose controlar la actividad hemol&#237;tica&#44; y una vez realizamos el diagn&#243;stico de SHUa&#44; cambiamos el tratamiento a eculizumab&#44; obteniendo buena respuesta&#44; sin requerir nuevos recambios plasm&#225;ticos y sin presentar reca&#237;das &#40;<a class="elsevierStyleCrossRef" href="#fig0005">fig&#46; 1</a>&#41;&#46; Sin embargo&#44; qued&#243; como secuela ERCT&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">El SHUa es una enfermedad gen&#233;tica ultra-rara que afecta a ni&#241;os y adultos&#44; caracterizada por la presencia de anemia hemol&#237;tica microangiop&#225;tica no inmune&#44; trombocitopenia y compromiso multiorg&#225;nico&#46; Su curso cl&#237;nico puede ser devastador y comprometer la vida o la integridad de los pacientes&#44; dejando secuelas graves como la ERCT&#46; El tratamiento con eculizumab debe ser iniciado precozmente para frenar el da&#241;o multiorg&#225;nico y evitar la muerte&#46;</p><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicto de intereses</span><p id="par0030" class="elsevierStylePara elsevierViewall">El Dr&#46; Nieto-R&#237;os y la Dra&#46; Serna-Higuita han dictado charlas sobre microangiopat&#237;a tromb&#243;tica patrocinadas por Alexion Pharma&#46; Los otros autores declaran no tener conflicto de inter&#233;s con el contenido de este art&#237;culo&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:2 [
        0 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Conflicto de intereses"
        ]
        1 => array:1 [
          "titulo" => "Bibliograf&#237;a"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "multimedia" => array:2 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1906
            "Ancho" => 2492
            "Tamanyo" => 284593
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Evoluci&#243;n de los ex&#225;menes de laboratorio durante el tratamiento&#46;</p> <p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Evoluci&#243;n de los par&#225;metros de laboratorio durante el tratamiento recibido&#58; recambios plasm&#225;ticos 13 sesiones &#40;flecha azules&#41;&#44; transfusiones total 4 &#40;flecha roja&#41;&#59; adem&#225;s&#44; se inici&#243; eculizumab el 29 de septiembre de 2014 &#40;flecha verde&#41;&#46; Los valores de LDH se encuentran en escala de 1<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleSup">2</span> y los valores de plaquetas se encuentran en escala de 1<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleSup">4</span>&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabla 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Ac MPO&#58; anticuerpos antimieloperoxidasa&#59; Ac PR3&#58; anticuerpos antiproteinasa 3&#59; ALT&#58; alanino aminotransferasa&#59; ANA&#58; anticuerpos antinucleares&#59; AST&#58; aspartato aminotransferasa&#59; BD&#58; bilirrubina directa&#59; BI&#58; bilirrubina indirecta&#59; BT&#58; bilirrubina total&#59; BUN&#58; nitr&#243;geno ureico&#59; CAP&#58; campo de alto poder&#59; Colesterol-LDL&#58; colesterol de baja densidad&#59; Colesterol-HDL&#58; colesterol de alta densidad&#59; C3&#58; complemento C3&#59; C4&#58; complemento C4&#59; ENA&#58; anticuerpos contra los ant&#237;genos extra&#237;bles del n&#250;cleo anti-RNP&#44; Sm&#44; Ro y La&#59; ESP&#58; extendido de sangre perif&#233;rica&#59; FA&#58; fosfatasa alcalina&#59; HCO<span class="elsevierStyleInf">3</span>&#58; bicarbonato s&#233;rico&#59; LDH&#58; lactato deshidrogenasa&#59; PCO<span class="elsevierStyleInf">2</span>&#58; presi&#243;n de di&#243;xido de carbono&#59; PO<span class="elsevierStyleInf">2</span>&#58; presi&#243;n de ox&#237;geno&#59; PTH&#58; paratohormona&#59; TAC&#58; tomograf&#237;a axial computarizada&#59; VIH&#58; anticuerpo virus de la inmunodeficiencia humana&#59; VRDL&#58; prueba no trepon&#233;mica para s&#237;filis&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " rowspan="2" align="left" valign="top">Citoqu&#237;mico de orina</td><td class="td" title="table-entry  " align="left" valign="top">Aspecto&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">pH&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Densidad&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Proteinuria&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Eritrocitos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Leucocitos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Proteinuria&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Turbio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">8&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;015&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#62;<span class="elsevierStyleHsp" style=""></span>300<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#62;<span class="elsevierStyleHsp" style=""></span>50<span class="elsevierStyleHsp" style=""></span>CAP&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">21-50<span class="elsevierStyleHsp" style=""></span>CAP&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">850<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " rowspan="2" align="left" valign="top">Gases capilares</td><td class="td" title="table-entry  " align="left" valign="top">pH&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">HCO<span class="elsevierStyleInf">3</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">PCO<span class="elsevierStyleInf">2</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">PO<span class="elsevierStyleInf">2</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">PAFI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Lactato&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Exceso bases&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">7&#44;24&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">9&#44;6<span class="elsevierStyleHsp" style=""></span>mmol&#47;l&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">22<span class="elsevierStyleHsp" style=""></span>mmHg&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">121<span class="elsevierStyleHsp" style=""></span>mmHg&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">242&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;3<span class="elsevierStyleHsp" style=""></span>mmol&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#8722;15&#44;7<span class="elsevierStyleHsp" style=""></span>mmol&#47;l&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " rowspan="6" align="left" valign="top">Perfil renal y metab&#243;lico</td><td class="td" title="table-entry  " align="left" valign="top">Creatinina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">BUN&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#193;cido &#250;rico&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Sodio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Potasio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Cloro&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">F&#243;sforo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">19&#44;7<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">128<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">8&#44;5<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">140<span class="elsevierStyleHsp" style=""></span>mEq&#47;l&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">4&#44;2<span class="elsevierStyleHsp" style=""></span>mEq&#47;l&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">100<span class="elsevierStyleHsp" style=""></span>mEq&#47;l&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">8<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Calcio corregido&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Calcio ionizado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Magnesio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Alb&#250;mina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Glucemia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Colesterol total&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Colesterol-HDL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">6&#44;7<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;65<span class="elsevierStyleHsp" style=""></span>mmol&#47;l&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;53<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#44;8<span class="elsevierStyleHsp" style=""></span>g&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">92<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">108<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">31<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Colesterol-LDL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Triglic&#233;ridos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Vitamina D&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">PTH&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Vitamina B<span class="elsevierStyleInf">12</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Ferritina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#193;cido f&#243;lico&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">63&#44;6<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">61<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">19&#44;3<span class="elsevierStyleHsp" style=""></span>ng&#47;ml&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">751<span class="elsevierStyleHsp" style=""></span>pg&#47;ml&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">286<span class="elsevierStyleHsp" style=""></span>pg&#47;ml&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">551<span class="elsevierStyleHsp" style=""></span>ng&#47;ml&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">7&#44;7<span class="elsevierStyleHsp" style=""></span>ng&#47;ml&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " rowspan="6" align="left" valign="top">Perfil hematol&#243;gico</td><td class="td" title="table-entry  " align="left" valign="top">Hemoglobina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Hematocrito&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Leucocitos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Neutr&#243;filos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Linfocitos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Monocitos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Bas&#243;filos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">5&#44;1<span class="elsevierStyleHsp" style=""></span>g&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">14&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">6&#46;200<span class="elsevierStyleHsp" style=""></span>mm<span class="elsevierStyleSup">3</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">80&#44;2&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">11&#44;3&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">8&#44;1&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;4&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Eosin&#243;filos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Plaquetas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Reticulocitos corregido&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">ESP&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">LDH&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Haptoglobina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Actividad ADAMTS13&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">0&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">82&#46;000<span class="elsevierStyleHsp" style=""></span>mm<span class="elsevierStyleSup">3</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">5&#44;2&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Esquistocitos &#43;&#43;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">547<span class="elsevierStyleHsp" style=""></span>u&#47;l&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10&#44;6<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">74&#44;5&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">TPT&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Control TPT&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">TP&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">INR&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Fibrin&#243;geno&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">30<span class="elsevierStyleHsp" style=""></span>s&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">26&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">11&#44;3<span class="elsevierStyleHsp" style=""></span>s&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;04&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">435<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " rowspan="2" align="left" valign="top">Perfil hep&#225;tico</td><td class="td" title="table-entry  " align="left" valign="top">BT&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">BD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">BI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">AST&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">ALT&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">FA&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">1&#44;5<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;4<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;1<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">22<span class="elsevierStyleHsp" style=""></span>U&#47;l&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">18<span class="elsevierStyleHsp" style=""></span>U&#47;l&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">77<span class="elsevierStyleHsp" style=""></span>U&#47;l&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " rowspan="2" align="left" valign="top">Estudios inmunol&#243;gicos</td><td class="td" title="table-entry  " align="left" valign="top">C3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">C4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">ANA&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">ENA&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Ac MPO&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Ac PR3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Coombs directo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">106<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">28&#44;8<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Negativos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Negativos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Negativos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Negativos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Negativo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Estudio gen&#233;tico del complemento&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " colspan="7" align="left" valign="top">No se encontraron mutaciones patol&#243;gicas en&#58; ADAMTS13&#44; C3&#44; CD46&#44; CFB&#44; CFH&#44; CFHR1&#44; CFHR2&#44; CFHR3&#44; CFHR4&#44; CFHR5&#44; CFI&#44; DGKE&#44; PIGA&#44; THBD</td></tr><tr title="table-row"><td class="td" title="table-entry  " rowspan="4" align="left" valign="top">Otros estudios</td><td class="td" title="table-entry  " colspan="2" align="left" valign="top">Electroforesis de prote&#237;nas</td><td class="td" title="table-entry  " align="left" valign="top">VIH&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Hepatitis B&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Hepatitis C&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">VDRL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Biopsia renal&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top">Hipoalbuminemia&#44; elevaci&#243;n inespec&#237;fica de la banda alfa 1 y B2</td><td class="td" title="table-entry  " align="left" valign="top">Negativo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Negativo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Negativo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Negativo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Microangiopat&#237;a tromb&#243;tica&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top">TAC de cr&#225;neo simple</td><td class="td" title="table-entry  " colspan="2" align="left" valign="top">Ecocardiograf&#237;a</td><td class="td" title="table-entry  " colspan="3" align="left" valign="top">Ecograf&#237;a renal</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top">Normal</td><td class="td" title="table-entry  " colspan="2" align="left" valign="top">Hipertensi&#243;n pulmonar y derrame peric&#225;rdico leve</td><td class="td" title="table-entry  " colspan="3" align="left" valign="top">Ri&#241;ones peque&#241;os&#44; ecog&#233;nicos&#44; con p&#233;rdida de la diferenciaci&#243;n corticomedular</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab989358.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Resultados de laboratorio</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:10 [
            0 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "An update for atypical haemolytic uraemic syndrome&#58; Diagnosis and treatment&#46; A consensus document"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Campistol"
                            1 => "M&#46; Arias"
                            2 => "G&#46; Ariceta"
                            3 => "M&#46; Blasco"
                            4 => "M&#46; Espinosa"
                            5 => "J&#46; Griny&#243;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3265/Nefrologia.pre2012.Nov.11781"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nefrologia&#46;"
                        "fecha" => "2013"
                        "volumen" => "33"
                        "paginaInicial" => "27"
                        "paginaFinal" => "45"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23364625"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Atypical hemolytic-uremic syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "M&#46; Noris"
                            1 => "G&#46; Remuzzi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMra0902814"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2009"
                        "volumen" => "361"
                        "paginaInicial" => "1676"
                        "paginaFinal" => "1687"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19846853"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Myocardial infarction is a complication of factor H-associated atypical HUS"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Sall&#233;e"
                            1 => "L&#46; Daniel"
                            2 => "M&#46; Piercecchi"
                            3 => "D&#46; Jaubert"
                            4 => "V&#46; Fremeaux-Bacchi"
                            5 => "Y&#46; Berland"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/ndt/gfq160"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nephrol Dial Transplant&#46;"
                        "fecha" => "2010"
                        "volumen" => "25"
                        "paginaInicial" => "2028"
                        "paginaFinal" => "2032"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20305136"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Syndromes of thrombotic microangiopathy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "J&#46; George"
                            1 => "C&#46; Nester"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMra1312353"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2014"
                        "volumen" => "371"
                        "paginaInicial" => "654"
                        "paginaFinal" => "666"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25119611"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "FSG for aHUS&#47;C3G&#46; Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "J&#46; Zuber"
                            1 => "F&#46; Fakhouri"
                            2 => "L&#46; Roumenina"
                            3 => "C&#46; Loirat"
                            4 => "V&#46; Fr&#233;meaux-Bacchi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/nrneph.2012.214"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nat Rev Nephrol&#46;"
                        "fecha" => "2012"
                        "volumen" => "8"
                        "paginaInicial" => "643"
                        "paginaFinal" => "657"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23026949"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical practice&#46; Thrombotic thrombocytopenic purpura"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "J&#46; George"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMcp053024"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2006"
                        "volumen" => "354"
                        "paginaInicial" => "1927"
                        "paginaFinal" => "1935"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16672704"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "National Institute for Health and Care Excellence&#46; Eculizumab for treating atypical haemolytic uraemic syndrome&#46; January 2015&#46; &#91;consultado 10 Feb 2015&#93;&#46; Disponible en&#58; https&#58;&#47;&#47;www&#46;nice&#46;org&#46;uk&#47;guidance&#47;hst1"
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "R&#46; Rother"
                            1 => "S&#46; Rollins"
                            2 => "C&#46; Mojcik"
                            3 => "R&#46; Brodsky"
                            4 => "L&#46; Bell"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/nbt1344"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nat Biotechnol&#46;"
                        "fecha" => "2007"
                        "volumen" => "25"
                        "paginaInicial" => "1256"
                        "paginaFinal" => "1264"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17989688"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Licht"
                            1 => "L&#46; Greenbaum"
                            2 => "P&#46; Muus"
                            3 => "S&#46; Babu"
                            4 => "C&#46; Bedrosian"
                            5 => "D&#46; Cohen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/ki.2014.423"
                      "Revista" => array:6 [
                        "tituloSerie" => "Kidney Int&#46;"
                        "fecha" => "2015"
                        "volumen" => "87"
                        "paginaInicial" => "1061"
                        "paginaFinal" => "1073"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25651368"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Noris"
                            1 => "J&#46; Caprioli"
                            2 => "E&#46; Bresin"
                            3 => "C&#46; Mossali"
                            4 => "G&#46; Pianetti"
                            5 => "S&#46; Gamba"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2215/CJN.02210310"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin J Am Soc Nephrol&#46;"
                        "fecha" => "2010"
                        "volumen" => "5"
                        "paginaInicial" => "1844"
                        "paginaFinal" => "1859"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20595690"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/02116995/0000003600000001/v1_201602110042/S0211699515001563/v1_201602110042/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "48186"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Cartas al Director"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/0000003600000001/v1_201602110042/S0211699515001563/v1_201602110042/es/main.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699515001563?idApp=UINPBA000064"
]
Compartir
Información de la revista

Estadísticas

Siga este enlace para acceder al texto completo del artículo

Carta al Director
Síndrome hemolítico urémico atípico en un paciente joven con compromiso renal, neurológico, ocular y cardiovascular
Atypical haemolytic-uraemic syndrome in a young patient with renal, neurological, ocular and cardiovascular involvement
John Fredy Nieto-Ríosa, Lina María Serna-Higuitaa,
Autor para correspondencia
, Estefanía Calle-Boterob, Catalina Ocampo-Kohna, Arbey Aristizabal-Alzatea, Mónica Zuluaga-Quinterob, Gustavo Zuluaga-Valenciaa
a Nefrólogo Hospital Pablo Tobón Uribe–Universidad de Antioquia, Medellín, Colombia
b Residente de Medicina Interna Universidad Pontificia Bolivariana, Medellín, Colombia
Leído
13054
Veces
se ha leído el artículo
2792
Total PDF
10262
Total HTML
Compartir estadísticas
 array:25 [
  "pii" => "S0211699515001563"
  "issn" => "02116995"
  "doi" => "10.1016/j.nefro.2015.07.008"
  "estado" => "S300"
  "fechaPublicacion" => "2016-01-01"
  "aid" => "104"
  "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
  "copyrightAnyo" => "2015"
  "documento" => "simple-article"
  "crossmark" => 0
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "cor"
  "cita" => "Nefrologia. 2016;36:82-5"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 5702
    "formatos" => array:3 [
      "EPUB" => 293
      "HTML" => 4655
      "PDF" => 754
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:20 [
      "pii" => "S2013251416000092"
      "issn" => "20132514"
      "doi" => "10.1016/j.nefroe.2016.01.008"
      "estado" => "S300"
      "fechaPublicacion" => "2016-01-01"
      "aid" => "104"
      "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
      "documento" => "simple-article"
      "crossmark" => 0
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "cor"
      "cita" => "Nefrologia &#40;English Version&#41;. 2016;36:82-5"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 4074
        "formatos" => array:3 [
          "EPUB" => 290
          "HTML" => 3156
          "PDF" => 628
        ]
      ]
      "en" => array:11 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>"
        "titulo" => "Atypical haemolytic-uraemic syndrome in a young patient with renal&#44; neurological&#44; ocular and cardiovascular involvement"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "82"
            "paginaFinal" => "85"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "S&#237;ndrome hemol&#237;tico ur&#233;mico at&#237;pico en un paciente joven con compromiso renal&#44; neurol&#243;gico&#44; ocular y cardiovascular"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0005"
            "etiqueta" => "Fig&#46; 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 1906
                "Ancho" => 2492
                "Tamanyo" => 304841
              ]
            ]
            "descripcion" => array:1 [
              "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Results of laboratory investigations during treatment&#46;</p> <p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Laboratory parameters during treatment&#58; 13 sessions of plasma exchange &#40;blue arrows&#41;&#59; total 4 red cell transfusions &#40;red arrow&#41;&#59; eculizumab&#44; started on 29 September 2014 &#40;green arrow&#41;&#46; The LDH values are at a scale of 1<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleSup">2</span> and the platelet values are at a scale of 1<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>10<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">4</span></a>&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "John Fredy Nieto-R&#237;os, Lina Mar&#237;a Serna-Higuita, Estefan&#237;a Calle-Botero, Catalina Ocampo-Kohn, Arbey Aristizabal-Alzate, M&#243;nica Zuluaga-Quintero, Gustavo Zuluaga-Valencia"
            "autores" => array:7 [
              0 => array:2 [
                "nombre" => "John Fredy"
                "apellidos" => "Nieto-R&#237;os"
              ]
              1 => array:2 [
                "nombre" => "Lina Mar&#237;a"
                "apellidos" => "Serna-Higuita"
              ]
              2 => array:2 [
                "nombre" => "Estefan&#237;a"
                "apellidos" => "Calle-Botero"
              ]
              3 => array:2 [
                "nombre" => "Catalina"
                "apellidos" => "Ocampo-Kohn"
              ]
              4 => array:2 [
                "nombre" => "Arbey"
                "apellidos" => "Aristizabal-Alzate"
              ]
              5 => array:2 [
                "nombre" => "M&#243;nica"
                "apellidos" => "Zuluaga-Quintero"
              ]
              6 => array:2 [
                "nombre" => "Gustavo"
                "apellidos" => "Zuluaga-Valencia"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "es" => array:9 [
          "pii" => "S0211699515001563"
          "doi" => "10.1016/j.nefro.2015.07.008"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "es"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699515001563?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251416000092?idApp=UINPBA000064"
      "url" => "/20132514/0000003600000001/v2_201703300133/S2013251416000092/v2_201703300133/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S021169951500154X"
    "issn" => "02116995"
    "doi" => "10.1016/j.nefro.2015.08.006"
    "estado" => "S300"
    "fechaPublicacion" => "2016-01-01"
    "aid" => "102"
    "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "cor"
    "cita" => "Nefrologia. 2016;36:85-6"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 4731
      "formatos" => array:3 [
        "EPUB" => 366
        "HTML" => 3629
        "PDF" => 736
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>"
      "titulo" => "An unusual case of peritonitis after vaginal leak in a patient on peritoneal dialysis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "85"
          "paginaFinal" => "86"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Un caso infrecuente de peritonitis tras fuga vaginal en un paciente en di&#225;lisis peritoneal"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1606
              "Ancho" => 900
              "Tamanyo" => 146504
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Arrows shows vaginal leak&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Ali Bakan, Alihan Oral, Osman Kostek, Sabahat Al&#305;&#351;&#305;r Ecder, Ali R&#305;za Odaba&#351;"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "Ali"
              "apellidos" => "Bakan"
            ]
            1 => array:2 [
              "nombre" => "Alihan"
              "apellidos" => "Oral"
            ]
            2 => array:2 [
              "nombre" => "Osman"
              "apellidos" => "Kostek"
            ]
            3 => array:2 [
              "nombre" => "Sabahat Al&#305;&#351;&#305;r"
              "apellidos" => "Ecder"
            ]
            4 => array:2 [
              "nombre" => "Ali R&#305;za"
              "apellidos" => "Odaba&#351;"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S021169951500154X?idApp=UINPBA000064"
    "url" => "/02116995/0000003600000001/v1_201602110042/S021169951500154X/v1_201602110042/en/main.assets"
  ]
  "itemAnterior" => array:20 [
    "pii" => "S0211699515001666"
    "issn" => "02116995"
    "doi" => "10.1016/j.nefro.2015.08.010"
    "estado" => "S300"
    "fechaPublicacion" => "2016-01-01"
    "aid" => "114"
    "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "cor"
    "cita" => "Nefrologia. 2016;36:80-1"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 10311
      "formatos" => array:3 [
        "EPUB" => 330
        "HTML" => 9207
        "PDF" => 774
      ]
    ]
    "es" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>"
      "titulo" => "Una causa infrecuente de hemoperitoneo espont&#225;neo en un paciente en di&#225;lisis peritoneal"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "80"
          "paginaFinal" => "81"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "An uncommon cause of spontaneous hemoperitoneum in a peritoneal dialysis patient"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 976
              "Ancho" => 897
              "Tamanyo" => 174069
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Imagen en TAC de un n&#243;dulo hiperdenso en la regi&#243;n posterior del fundus g&#225;strico&#44; compatible con seudoaneurisma de la arteria g&#225;strica izquierda&#44; con un hematoma subyacente&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Carlos Hidalgo-Ordo&#241;ez, J&#46; Emilio S&#225;nchez-Alvarez, Carmen Rodr&#237;guez-Su&#225;rez"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Carlos"
              "apellidos" => "Hidalgo-Ordo&#241;ez"
            ]
            1 => array:2 [
              "nombre" => "J&#46; Emilio"
              "apellidos" => "S&#225;nchez-Alvarez"
            ]
            2 => array:2 [
              "nombre" => "Carmen"
              "apellidos" => "Rodr&#237;guez-Su&#225;rez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S2013251416000316"
        "doi" => "10.1016/j.nefroe.2016.03.001"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251416000316?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699515001666?idApp=UINPBA000064"
    "url" => "/02116995/0000003600000001/v1_201602110042/S0211699515001666/v1_201602110042/es/main.assets"
  ]
  "es" => array:15 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>"
    "titulo" => "S&#237;ndrome hemol&#237;tico ur&#233;mico at&#237;pico en un paciente joven con compromiso renal&#44; neurol&#243;gico&#44; ocular y cardiovascular"
    "tieneTextoCompleto" => true
    "saludo" => "<span class="elsevierStyleItalic">Sr&#46; Director&#58;</span>"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "82"
        "paginaFinal" => "85"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "John Fredy Nieto-R&#237;os, Lina Mar&#237;a Serna-Higuita, Estefan&#237;a Calle-Botero, Catalina Ocampo-Kohn, Arbey Aristizabal-Alzate, M&#243;nica Zuluaga-Quintero, Gustavo Zuluaga-Valencia"
        "autores" => array:7 [
          0 => array:3 [
            "nombre" => "John Fredy"
            "apellidos" => "Nieto-R&#237;os"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          1 => array:4 [
            "nombre" => "Lina Mar&#237;a"
            "apellidos" => "Serna-Higuita"
            "email" => array:2 [
              0 => "lm&#46;serna&#64;hotmail&#46;com"
              1 => "johnfredynieto&#64;gmail&#46;com"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Estefan&#237;a"
            "apellidos" => "Calle-Botero"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Catalina"
            "apellidos" => "Ocampo-Kohn"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "Arbey"
            "apellidos" => "Aristizabal-Alzate"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "M&#243;nica"
            "apellidos" => "Zuluaga-Quintero"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          6 => array:3 [
            "nombre" => "Gustavo"
            "apellidos" => "Zuluaga-Valencia"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:3 [
            "entidad" => "Nefr&#243;logo Hospital Pablo Tob&#243;n Uribe&#8211;Universidad de Antioquia&#44; Medell&#237;n&#44; Colombia"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Residente de Medicina Interna Universidad Pontificia Bolivariana&#44; Medell&#237;n&#44; Colombia"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "<span class="elsevierStyleItalic">Autor para correspondencia</span>&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Atypical haemolytic-uraemic syndrome in a young patient with renal&#44; neurological&#44; ocular and cardiovascular involvement"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1906
            "Ancho" => 2492
            "Tamanyo" => 284593
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Evoluci&#243;n de los ex&#225;menes de laboratorio durante el tratamiento&#46;</p> <p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Evoluci&#243;n de los par&#225;metros de laboratorio durante el tratamiento recibido&#58; recambios plasm&#225;ticos 13 sesiones &#40;flecha azules&#41;&#44; transfusiones total 4 &#40;flecha roja&#41;&#59; adem&#225;s&#44; se inici&#243; eculizumab el 29 de septiembre de 2014 &#40;flecha verde&#41;&#46; Los valores de LDH se encuentran en escala de 1<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleSup">2</span> y los valores de plaquetas se encuentran en escala de 1<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleSup">4</span>&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Presentamos el caso de un paciente de 23 a&#241;os&#44; con 3 meses de evoluci&#243;n de cefalea&#44; p&#233;rdida de la visi&#243;n&#44; hiporexia y orina espumosa&#46; En la &#250;ltima semana&#58; postraci&#243;n en cama&#44; alteraci&#243;n del sensorio&#44; oliguria y disnea&#46; En la evaluaci&#243;n inicial se encontr&#243; en malas condiciones generales&#44; somnoliento&#44; desorientado&#44; taquic&#225;rdico&#44; hipertenso&#44; taquipneico&#44; con asterixis&#59; aliento ur&#233;mico e ingurgitaci&#243;n yugular&#59; ruidos respiratorios con cr&#233;pitos bibasales y edema de miembros inferiores&#46; Pruebas de laboratorio al ingreso&#58; azoados elevados&#44; acidosis metab&#243;lica con ani&#243;n GAP alto&#44; anemia hemol&#237;tica microangiop&#225;tica no inmune y trombocitopenia &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41;&#46; Se solicitaron estudios complementarios&#44; incluida actividad de ADAMTS13&#44; y perfil inmunol&#243;gico e infeccioso&#44; que fueron negativos &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41;&#46; Se inici&#243; tratamiento con hemodi&#225;lisis&#44; labetalol parenteral&#44; transfusi&#243;n de gl&#243;bulos rojos y recambios plasm&#225;ticos&#46; Una vez controlada la uremia y la crisis hipertensiva se realiz&#243; una evaluaci&#243;n oftalmol&#243;gica que report&#243; p&#233;rdida marcada de la agudeza visual &#40;OD&#58; 20&#47;400<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>1&#59; OI&#58; 20&#47;150<span class="elsevierStyleHsp" style=""></span>&#8722;<span class="elsevierStyleHsp" style=""></span>1&#41; y retinopat&#237;a hipertensiva&#46; Al s&#233;ptimo d&#237;a se control&#243; la actividad hemol&#237;tica&#44; lo que permiti&#243; suspender los recambios plasm&#225;ticos&#59; sin embargo&#44; present&#243; reca&#237;da 48<span class="elsevierStyleHsp" style=""></span>h despu&#233;s&#44; raz&#243;n por la cual se reiniciaron nuevamente y se obtuvo el diagn&#243;stico definitivo de SHUa &#40;<a class="elsevierStyleCrossRef" href="#fig0005">fig&#46; 1</a>&#41;&#46; Se inici&#243; tratamiento con eculizumab y se suspendieron los recambios plasm&#225;ticos&#44; con adecuada evoluci&#243;n posterior&#44; con recuperaci&#243;n de su visi&#243;n &#40;20&#47;30 en ambos ojos&#41;&#44; aunque continu&#243; con requerimiento de di&#225;lisis&#46; Se realiz&#243; estudio gen&#233;tico para detectar mutaciones del complemento asociadas con SHUa&#44; el cual fue negativo para las mutaciones conocidas &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41;&#46; En el seguimiento a 9 meses el paciente continuaba dependiente de di&#225;lisis&#44; por lo cual se diagnostic&#243; enfermedad renal cr&#243;nica terminal &#40;ERCT&#41; secundaria a SHUa y se activ&#243; para trasplante renal&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0010" class="elsevierStylePara elsevierViewall">El SHUa es una enfermedad gen&#233;tica cr&#243;nica ultra-rara&#44; ocasionada por una alteraci&#243;n en la regulaci&#243;n del complemento y que puede producir secuelas graves en m&#250;ltiples &#243;rganos e incluso la muerte<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#8211;4</span></a>&#46; Se caracteriza por la tr&#237;ada de anemia hemol&#237;tica microangiop&#225;tica&#44; trombocitopenia e insuficiencia renal&#44; pero puede producir alteraci&#243;n en cualquier &#243;rgano<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;2</span></a>&#46; Nuestro paciente present&#243; compromiso renal&#44; hematol&#243;gico&#44; neurol&#243;gico&#44; cardiovascular y ocular&#44; este &#250;ltimo hallazgo&#44; poco reportado en la literatura<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;2</span></a>&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">En m&#225;s de la mitad de los pacientes con SHUa se puede identificar la mutaci&#243;n del complemento o de otras mol&#233;culas que ocasiona la alteraci&#243;n en su regulaci&#243;n&#59; sin embargo&#44; no se requiere el estudio gen&#233;tico para confirmar el diagn&#243;stico e iniciar el tratamiento&#44; pero s&#237; es ideal realizarlo para establecer el pron&#243;stico&#44; ya que hay algunas mutaciones m&#225;s agresivas que otras&#59; adem&#225;s&#44; el estudio gen&#233;tico permite planear de una forma m&#225;s adecuada el trasplante renal en los pacientes que lo requieren<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;2&#44;5</span></a>&#46; Hasta en el 30&#37; de los enfermos no se documenta mutaci&#243;n<a class="elsevierStyleCrossRefs" href="#bib0070"><span class="elsevierStyleSup">4&#44;6</span></a>&#44; como fue el caso de nuestro paciente&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">El tratamiento de elecci&#243;n del SHUa es eculizumab&#44; anticuerpo monoclonal humanizado que bloquea la escisi&#243;n de la fracci&#243;n C5 del complemento y&#44; por lo tanto&#44; evita la liberaci&#243;n de la anafilotoxina C5a y la formaci&#243;n del complejo de ataque de membrana C5b-9&#44; evitando as&#237; el da&#241;o endotelial y la generaci&#243;n de microangiopat&#237;a tromb&#243;tica<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;7&#44;8</span></a>&#46; Como prerrequisito para el inicio de eculizumab se debe aplicar la vacuna contra el meningococo e iniciar profilaxis antibi&#243;tica dirigida al meningococo&#44; mientras la vacuna surte efecto&#46; Cuanto m&#225;s r&#225;pido se inicie eculizumab en los pacientes con SHUa&#44; mayor ser&#225; la posibilidad de recuperaci&#243;n y menores ser&#225;n las secuelas<a class="elsevierStyleCrossRefs" href="#bib0075"><span class="elsevierStyleSup">5&#44;9</span></a>&#46; Sin embargo&#44; mientras se realiza el diagn&#243;stico de este s&#237;ndrome&#44; los recambios plasm&#225;ticos pueden estabilizar la actividad hemol&#237;tica del paciente y&#44; por lo tanto&#44; se deben iniciar precozmente ante el cuadro cl&#237;nico de una microangiopat&#237;a tromb&#243;tica&#44; teniendo en cuenta que se debe tomar previamente la actividad de la ADAMTS13 y el perfil de autoanticuerpos para no enmascarar otros diagn&#243;sticos<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;5&#44;7</span></a>&#46; Si al final el diagn&#243;stico es un SHUa&#44; el tratamiento debe ser cambiado a eculizumab&#44; ya que la terapia plasm&#225;tica a largo plazo no ha mostrado cambiar el curso devastador del SHUa<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;5&#44;9&#44;10</span></a>&#46; En el caso de nuestro paciente&#44; inicialmente se realizaron recambios plasm&#225;ticos&#44; logr&#225;ndose controlar la actividad hemol&#237;tica&#44; y una vez realizamos el diagn&#243;stico de SHUa&#44; cambiamos el tratamiento a eculizumab&#44; obteniendo buena respuesta&#44; sin requerir nuevos recambios plasm&#225;ticos y sin presentar reca&#237;das &#40;<a class="elsevierStyleCrossRef" href="#fig0005">fig&#46; 1</a>&#41;&#46; Sin embargo&#44; qued&#243; como secuela ERCT&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">El SHUa es una enfermedad gen&#233;tica ultra-rara que afecta a ni&#241;os y adultos&#44; caracterizada por la presencia de anemia hemol&#237;tica microangiop&#225;tica no inmune&#44; trombocitopenia y compromiso multiorg&#225;nico&#46; Su curso cl&#237;nico puede ser devastador y comprometer la vida o la integridad de los pacientes&#44; dejando secuelas graves como la ERCT&#46; El tratamiento con eculizumab debe ser iniciado precozmente para frenar el da&#241;o multiorg&#225;nico y evitar la muerte&#46;</p><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicto de intereses</span><p id="par0030" class="elsevierStylePara elsevierViewall">El Dr&#46; Nieto-R&#237;os y la Dra&#46; Serna-Higuita han dictado charlas sobre microangiopat&#237;a tromb&#243;tica patrocinadas por Alexion Pharma&#46; Los otros autores declaran no tener conflicto de inter&#233;s con el contenido de este art&#237;culo&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:2 [
        0 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Conflicto de intereses"
        ]
        1 => array:1 [
          "titulo" => "Bibliograf&#237;a"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "multimedia" => array:2 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1906
            "Ancho" => 2492
            "Tamanyo" => 284593
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Evoluci&#243;n de los ex&#225;menes de laboratorio durante el tratamiento&#46;</p> <p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Evoluci&#243;n de los par&#225;metros de laboratorio durante el tratamiento recibido&#58; recambios plasm&#225;ticos 13 sesiones &#40;flecha azules&#41;&#44; transfusiones total 4 &#40;flecha roja&#41;&#59; adem&#225;s&#44; se inici&#243; eculizumab el 29 de septiembre de 2014 &#40;flecha verde&#41;&#46; Los valores de LDH se encuentran en escala de 1<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleSup">2</span> y los valores de plaquetas se encuentran en escala de 1<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleSup">4</span>&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabla 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Ac MPO&#58; anticuerpos antimieloperoxidasa&#59; Ac PR3&#58; anticuerpos antiproteinasa 3&#59; ALT&#58; alanino aminotransferasa&#59; ANA&#58; anticuerpos antinucleares&#59; AST&#58; aspartato aminotransferasa&#59; BD&#58; bilirrubina directa&#59; BI&#58; bilirrubina indirecta&#59; BT&#58; bilirrubina total&#59; BUN&#58; nitr&#243;geno ureico&#59; CAP&#58; campo de alto poder&#59; Colesterol-LDL&#58; colesterol de baja densidad&#59; Colesterol-HDL&#58; colesterol de alta densidad&#59; C3&#58; complemento C3&#59; C4&#58; complemento C4&#59; ENA&#58; anticuerpos contra los ant&#237;genos extra&#237;bles del n&#250;cleo anti-RNP&#44; Sm&#44; Ro y La&#59; ESP&#58; extendido de sangre perif&#233;rica&#59; FA&#58; fosfatasa alcalina&#59; HCO<span class="elsevierStyleInf">3</span>&#58; bicarbonato s&#233;rico&#59; LDH&#58; lactato deshidrogenasa&#59; PCO<span class="elsevierStyleInf">2</span>&#58; presi&#243;n de di&#243;xido de carbono&#59; PO<span class="elsevierStyleInf">2</span>&#58; presi&#243;n de ox&#237;geno&#59; PTH&#58; paratohormona&#59; TAC&#58; tomograf&#237;a axial computarizada&#59; VIH&#58; anticuerpo virus de la inmunodeficiencia humana&#59; VRDL&#58; prueba no trepon&#233;mica para s&#237;filis&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " rowspan="2" align="left" valign="top">Citoqu&#237;mico de orina</td><td class="td" title="table-entry  " align="left" valign="top">Aspecto&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">pH&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Densidad&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Proteinuria&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Eritrocitos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Leucocitos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Proteinuria&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Turbio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">8&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;015&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#62;<span class="elsevierStyleHsp" style=""></span>300<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#62;<span class="elsevierStyleHsp" style=""></span>50<span class="elsevierStyleHsp" style=""></span>CAP&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">21-50<span class="elsevierStyleHsp" style=""></span>CAP&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">850<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " rowspan="2" align="left" valign="top">Gases capilares</td><td class="td" title="table-entry  " align="left" valign="top">pH&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">HCO<span class="elsevierStyleInf">3</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">PCO<span class="elsevierStyleInf">2</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">PO<span class="elsevierStyleInf">2</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">PAFI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Lactato&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Exceso bases&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">7&#44;24&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">9&#44;6<span class="elsevierStyleHsp" style=""></span>mmol&#47;l&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">22<span class="elsevierStyleHsp" style=""></span>mmHg&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">121<span class="elsevierStyleHsp" style=""></span>mmHg&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">242&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;3<span class="elsevierStyleHsp" style=""></span>mmol&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#8722;15&#44;7<span class="elsevierStyleHsp" style=""></span>mmol&#47;l&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " rowspan="6" align="left" valign="top">Perfil renal y metab&#243;lico</td><td class="td" title="table-entry  " align="left" valign="top">Creatinina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">BUN&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#193;cido &#250;rico&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Sodio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Potasio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Cloro&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">F&#243;sforo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">19&#44;7<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">128<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">8&#44;5<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">140<span class="elsevierStyleHsp" style=""></span>mEq&#47;l&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">4&#44;2<span class="elsevierStyleHsp" style=""></span>mEq&#47;l&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">100<span class="elsevierStyleHsp" style=""></span>mEq&#47;l&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">8<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Calcio corregido&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Calcio ionizado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Magnesio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Alb&#250;mina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Glucemia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Colesterol total&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Colesterol-HDL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">6&#44;7<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;65<span class="elsevierStyleHsp" style=""></span>mmol&#47;l&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;53<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#44;8<span class="elsevierStyleHsp" style=""></span>g&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">92<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">108<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">31<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Colesterol-LDL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Triglic&#233;ridos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Vitamina D&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">PTH&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Vitamina B<span class="elsevierStyleInf">12</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Ferritina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#193;cido f&#243;lico&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">63&#44;6<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">61<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">19&#44;3<span class="elsevierStyleHsp" style=""></span>ng&#47;ml&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">751<span class="elsevierStyleHsp" style=""></span>pg&#47;ml&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">286<span class="elsevierStyleHsp" style=""></span>pg&#47;ml&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">551<span class="elsevierStyleHsp" style=""></span>ng&#47;ml&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">7&#44;7<span class="elsevierStyleHsp" style=""></span>ng&#47;ml&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " rowspan="6" align="left" valign="top">Perfil hematol&#243;gico</td><td class="td" title="table-entry  " align="left" valign="top">Hemoglobina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Hematocrito&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Leucocitos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Neutr&#243;filos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Linfocitos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Monocitos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Bas&#243;filos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">5&#44;1<span class="elsevierStyleHsp" style=""></span>g&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">14&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">6&#46;200<span class="elsevierStyleHsp" style=""></span>mm<span class="elsevierStyleSup">3</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">80&#44;2&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">11&#44;3&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">8&#44;1&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;4&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Eosin&#243;filos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Plaquetas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Reticulocitos corregido&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">ESP&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">LDH&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Haptoglobina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Actividad ADAMTS13&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">0&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">82&#46;000<span class="elsevierStyleHsp" style=""></span>mm<span class="elsevierStyleSup">3</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">5&#44;2&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Esquistocitos &#43;&#43;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">547<span class="elsevierStyleHsp" style=""></span>u&#47;l&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10&#44;6<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">74&#44;5&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">TPT&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Control TPT&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">TP&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">INR&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Fibrin&#243;geno&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">30<span class="elsevierStyleHsp" style=""></span>s&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">26&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">11&#44;3<span class="elsevierStyleHsp" style=""></span>s&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;04&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">435<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " rowspan="2" align="left" valign="top">Perfil hep&#225;tico</td><td class="td" title="table-entry  " align="left" valign="top">BT&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">BD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">BI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">AST&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">ALT&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">FA&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">1&#44;5<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;4<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;1<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">22<span class="elsevierStyleHsp" style=""></span>U&#47;l&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">18<span class="elsevierStyleHsp" style=""></span>U&#47;l&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">77<span class="elsevierStyleHsp" style=""></span>U&#47;l&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " rowspan="2" align="left" valign="top">Estudios inmunol&#243;gicos</td><td class="td" title="table-entry  " align="left" valign="top">C3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">C4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">ANA&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">ENA&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Ac MPO&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Ac PR3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Coombs directo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">106<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">28&#44;8<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Negativos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Negativos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Negativos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Negativos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Negativo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Estudio gen&#233;tico del complemento&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " colspan="7" align="left" valign="top">No se encontraron mutaciones patol&#243;gicas en&#58; ADAMTS13&#44; C3&#44; CD46&#44; CFB&#44; CFH&#44; CFHR1&#44; CFHR2&#44; CFHR3&#44; CFHR4&#44; CFHR5&#44; CFI&#44; DGKE&#44; PIGA&#44; THBD</td></tr><tr title="table-row"><td class="td" title="table-entry  " rowspan="4" align="left" valign="top">Otros estudios</td><td class="td" title="table-entry  " colspan="2" align="left" valign="top">Electroforesis de prote&#237;nas</td><td class="td" title="table-entry  " align="left" valign="top">VIH&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Hepatitis B&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Hepatitis C&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">VDRL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Biopsia renal&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top">Hipoalbuminemia&#44; elevaci&#243;n inespec&#237;fica de la banda alfa 1 y B2</td><td class="td" title="table-entry  " align="left" valign="top">Negativo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Negativo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Negativo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Negativo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Microangiopat&#237;a tromb&#243;tica&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top">TAC de cr&#225;neo simple</td><td class="td" title="table-entry  " colspan="2" align="left" valign="top">Ecocardiograf&#237;a</td><td class="td" title="table-entry  " colspan="3" align="left" valign="top">Ecograf&#237;a renal</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top">Normal</td><td class="td" title="table-entry  " colspan="2" align="left" valign="top">Hipertensi&#243;n pulmonar y derrame peric&#225;rdico leve</td><td class="td" title="table-entry  " colspan="3" align="left" valign="top">Ri&#241;ones peque&#241;os&#44; ecog&#233;nicos&#44; con p&#233;rdida de la diferenciaci&#243;n corticomedular</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab989358.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Resultados de laboratorio</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:10 [
            0 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "An update for atypical haemolytic uraemic syndrome&#58; Diagnosis and treatment&#46; A consensus document"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Campistol"
                            1 => "M&#46; Arias"
                            2 => "G&#46; Ariceta"
                            3 => "M&#46; Blasco"
                            4 => "M&#46; Espinosa"
                            5 => "J&#46; Griny&#243;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3265/Nefrologia.pre2012.Nov.11781"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nefrologia&#46;"
                        "fecha" => "2013"
                        "volumen" => "33"
                        "paginaInicial" => "27"
                        "paginaFinal" => "45"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23364625"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Atypical hemolytic-uremic syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "M&#46; Noris"
                            1 => "G&#46; Remuzzi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMra0902814"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2009"
                        "volumen" => "361"
                        "paginaInicial" => "1676"
                        "paginaFinal" => "1687"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19846853"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Myocardial infarction is a complication of factor H-associated atypical HUS"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Sall&#233;e"
                            1 => "L&#46; Daniel"
                            2 => "M&#46; Piercecchi"
                            3 => "D&#46; Jaubert"
                            4 => "V&#46; Fremeaux-Bacchi"
                            5 => "Y&#46; Berland"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/ndt/gfq160"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nephrol Dial Transplant&#46;"
                        "fecha" => "2010"
                        "volumen" => "25"
                        "paginaInicial" => "2028"
                        "paginaFinal" => "2032"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20305136"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Syndromes of thrombotic microangiopathy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "J&#46; George"
                            1 => "C&#46; Nester"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMra1312353"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2014"
                        "volumen" => "371"
                        "paginaInicial" => "654"
                        "paginaFinal" => "666"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25119611"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "FSG for aHUS&#47;C3G&#46; Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "J&#46; Zuber"
                            1 => "F&#46; Fakhouri"
                            2 => "L&#46; Roumenina"
                            3 => "C&#46; Loirat"
                            4 => "V&#46; Fr&#233;meaux-Bacchi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/nrneph.2012.214"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nat Rev Nephrol&#46;"
                        "fecha" => "2012"
                        "volumen" => "8"
                        "paginaInicial" => "643"
                        "paginaFinal" => "657"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23026949"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical practice&#46; Thrombotic thrombocytopenic purpura"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "J&#46; George"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMcp053024"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2006"
                        "volumen" => "354"
                        "paginaInicial" => "1927"
                        "paginaFinal" => "1935"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16672704"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "National Institute for Health and Care Excellence&#46; Eculizumab for treating atypical haemolytic uraemic syndrome&#46; January 2015&#46; &#91;consultado 10 Feb 2015&#93;&#46; Disponible en&#58; https&#58;&#47;&#47;www&#46;nice&#46;org&#46;uk&#47;guidance&#47;hst1"
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "R&#46; Rother"
                            1 => "S&#46; Rollins"
                            2 => "C&#46; Mojcik"
                            3 => "R&#46; Brodsky"
                            4 => "L&#46; Bell"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/nbt1344"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nat Biotechnol&#46;"
                        "fecha" => "2007"
                        "volumen" => "25"
                        "paginaInicial" => "1256"
                        "paginaFinal" => "1264"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17989688"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Licht"
                            1 => "L&#46; Greenbaum"
                            2 => "P&#46; Muus"
                            3 => "S&#46; Babu"
                            4 => "C&#46; Bedrosian"
                            5 => "D&#46; Cohen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/ki.2014.423"
                      "Revista" => array:6 [
                        "tituloSerie" => "Kidney Int&#46;"
                        "fecha" => "2015"
                        "volumen" => "87"
                        "paginaInicial" => "1061"
                        "paginaFinal" => "1073"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25651368"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Noris"
                            1 => "J&#46; Caprioli"
                            2 => "E&#46; Bresin"
                            3 => "C&#46; Mossali"
                            4 => "G&#46; Pianetti"
                            5 => "S&#46; Gamba"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2215/CJN.02210310"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin J Am Soc Nephrol&#46;"
                        "fecha" => "2010"
                        "volumen" => "5"
                        "paginaInicial" => "1844"
                        "paginaFinal" => "1859"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20595690"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/02116995/0000003600000001/v1_201602110042/S0211699515001563/v1_201602110042/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "48186"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Cartas al Director"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/0000003600000001/v1_201602110042/S0211699515001563/v1_201602110042/es/main.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699515001563?idApp=UINPBA000064"
]
Información del artículo
ISSN: 02116995
Idioma original: Español
Datos actualizados diariamente
año/Mes Html Pdf Total
2024 Noviembre 17 10 27
2024 Octubre 213 42 255
2024 Septiembre 168 28 196
2024 Agosto 168 60 228
2024 Julio 140 28 168
2024 Junio 161 41 202
2024 Mayo 119 27 146
2024 Abril 204 43 247
2024 Marzo 106 25 131
2024 Febrero 112 40 152
2024 Enero 113 26 139
2023 Diciembre 99 25 124
2023 Noviembre 122 35 157
2023 Octubre 175 36 211
2023 Septiembre 192 30 222
2023 Agosto 122 48 170
2023 Julio 103 25 128
2023 Junio 108 21 129
2023 Mayo 106 37 143
2023 Abril 82 22 104
2023 Marzo 108 30 138
2023 Febrero 75 22 97
2023 Enero 78 25 103
2022 Diciembre 59 32 91
2022 Noviembre 91 35 126
2022 Octubre 97 55 152
2022 Septiembre 82 46 128
2022 Agosto 60 50 110
2022 Julio 56 48 104
2022 Junio 48 43 91
2022 Mayo 68 43 111
2022 Abril 92 56 148
2022 Marzo 73 47 120
2022 Febrero 85 39 124
2022 Enero 76 43 119
2021 Diciembre 48 40 88
2021 Noviembre 110 54 164
2021 Octubre 65 40 105
2021 Septiembre 67 34 101
2021 Agosto 77 30 107
2021 Julio 90 41 131
2021 Junio 72 28 100
2021 Mayo 99 46 145
2021 Abril 147 48 195
2021 Marzo 111 42 153
2021 Febrero 63 35 98
2021 Enero 74 34 108
2020 Diciembre 51 25 76
2020 Noviembre 81 22 103
2020 Octubre 80 41 121
2020 Septiembre 79 29 108
2020 Agosto 60 31 91
2020 Julio 79 12 91
2020 Junio 72 34 106
2020 Mayo 106 36 142
2020 Abril 101 39 140
2020 Marzo 66 23 89
2020 Febrero 86 28 114
2020 Enero 62 31 93
2019 Diciembre 78 32 110
2019 Noviembre 75 36 111
2019 Octubre 75 21 96
2019 Septiembre 77 14 91
2019 Agosto 67 25 92
2019 Julio 37 21 58
2019 Junio 53 28 81
2019 Mayo 54 38 92
2019 Abril 97 36 133
2019 Marzo 59 28 87
2019 Febrero 41 20 61
2019 Enero 44 19 63
2018 Diciembre 113 46 159
2018 Noviembre 170 15 185
2018 Octubre 107 25 132
2018 Septiembre 68 8 76
2018 Agosto 56 7 63
2018 Julio 53 9 62
2018 Junio 68 7 75
2018 Mayo 80 12 92
2018 Abril 87 10 97
2018 Marzo 90 14 104
2018 Febrero 72 11 83
2018 Enero 88 9 97
2017 Diciembre 93 9 102
2017 Noviembre 77 10 87
2017 Octubre 59 5 64
2017 Septiembre 63 14 77
2017 Agosto 51 9 60
2017 Julio 43 9 52
2017 Junio 61 15 76
2017 Mayo 47 24 71
2017 Abril 42 7 49
2017 Marzo 41 34 75
2017 Febrero 35 15 50
2017 Enero 33 17 50
2016 Diciembre 80 3 83
2016 Noviembre 91 17 108
2016 Octubre 118 8 126
2016 Septiembre 182 11 193
2016 Agosto 167 1 168
2016 Julio 201 7 208
2016 Junio 151 0 151
2016 Mayo 208 0 208
2016 Abril 184 0 184
2016 Marzo 227 0 227
2016 Febrero 232 0 232
2016 Enero 77 0 77
2015 Diciembre 77 0 77
2015 Noviembre 89 0 89
Mostrar todo

Siga este enlace para acceder al texto completo del artículo

Idiomas
Nefrología
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?